Service Of Next Generation Sequencing Service And Data Analysis And Report Including Dna And Rna Sequencing From Human Tumour Samples, Paired With Sequencing Of Peripheral Blood Samples As A Control Sample By The Project Pi23/01045 Titled Immunotherapy In Triple Negative Breast Cancer (Portrait-Tnbc) ”Of The Foundation University Hospital Habron-Institut De Recerca (Vhir), Finded By Health Institute Carlos Iii (Isciii) And Co-Funded By The European Union.

Fundacio Hospital Universitari Vall d'Hebron - Institut de Recerca Spain has Released a tender for Service Of Next Generation Sequencing Service And Data Analysis And Report Including Dna And Rna Sequencing From Human Tumour Samples, Paired With Sequencing Of Peripheral Blood Samples As A Control Sample By The Project Pi23/01045 Titled Immunotherapy In Triple Negative Breast Cancer (Portrait-Tnbc) ”Of The Foundation University Hospital Habron-Institut De Recerca (Vhir), Finded By Health Institute Carlos Iii (Isciii) And Co-Funded By The European Union. in laboratory equipment and services . The tender was released on Mar 06, 2025.

Country - Spain

Summary - Service Of Next Generation Sequencing Service And Data Analysis And Report Including Dna And Rna Sequencing From Human Tumour Samples, Paired With Sequencing Of Peripheral Blood Samples As A Control Sample By The Project Pi23/01045 Titled Immunotherapy In Triple Negative Breast Cancer (Portrait-Tnbc) ”Of The Foundation University Hospital Habron-Institut De Recerca (Vhir), Finded By Health Institute Carlos Iii (Isciii) And Co-Funded By The European Union.

Deadline - Mar 20, 2025

GT reference number - 104485917

Product classification - Research laboratory services